Risk of Hospitalization and Death for COVID‐19 in People with Parkinson's Disease or Parkinsonism (original) (raw)

Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region

Valentino De Franco

Journal of Neurology

View PDFchevron_right

Predictors of COVID-19 outcome in Parkinson's disease

Carlo Dallocchio

Parkinsonism & Related Disorders, 2020

View PDFchevron_right

Vulnerability of Parkinson’s Patients to COVID-19 and Its Consequences and Effects on Them: A Systematic Review

Leila Shahmoradi

Parkinson's Disease

View PDFchevron_right

Effects of COVID ‐19 on Parkinson's Disease Clinical Features: A Community‐Based Case‐Control Study

Nico Golfrè Andreasi

Movement Disorders, 2020

View PDFchevron_right

COVID-19 and Parkinson’s Disease: What Do We Know So Far?

Carlo Alberto Artusi

Journal of Parkinson's Disease

View PDFchevron_right

A 6-month longitudinal study on worsening of Parkinson’s disease during the COVID-19 pandemic

Ali Shalash

npj Parkinson's Disease

View PDFchevron_right

Impact of the COVID-19 Pandemic on Patients with Parkinson’s Disease from the Perspective of Treating Physicians—A Nationwide Cross-Sectional Study

Erica Westenberg

Brain Sciences, 2022

View PDFchevron_right

Risk of SARS‐CoV ‐2 infection, hospitalization, and death for COVID ‐19 in people with Parkinson disease or parkinsonism over a 15‐month period: A cohort study

Sabina Cevoli

European Journal of Neurology

View PDFchevron_right

COVID-19 and Parkinson’s disease: a systematic review and meta-analysis

Yousef Moradi

Acta Neurologica Belgica

View PDFchevron_right

Comparison of Parkinson’s patients with and without COVID-19 in terms of prognosis

Fettah Eren

Neurology Asia, 2023

View PDFchevron_right

The Effects of COVID-19-Related Restrictions on Parkinson’s Disease Patients in Italy: Results of a Structured Survey

Marco Cosentino

Journal of Clinical Medicine

View PDFchevron_right

Worsened Parkinson’s Disease Progression: Impact of the COVID-19 Pandemic

Christian Ineichen

Journal of Parkinson's Disease

View PDFchevron_right

The impact of Parkinson's disease on manifestations and outcomes of Covid-19 patients: A systematic review and meta-analysis

Adam A Dmytriw

Reviews in Medical Virology, 2021

View PDFchevron_right

Potential impact and challenges associated with Parkinson’s disease patient care amidst the COVID-19 global pandemic

Ali Elbeddini

Journal of Clinical Movement Disorders

View PDFchevron_right

Secondary Impact of COVID-19 Pandemic on People with Parkinson’s Disease—Results of a Polish Online Survey

Anna Poznańska

Brain Sciences, 2021

View PDFchevron_right

Parkinson’s disease and COVID-19: a systematic review and meta-analysis

narges ebrahimi

Neurological Sciences

View PDFchevron_right

Effect of the coronavirus disease 2019 pandemic on people with Parkinson's disease: experience from a Croatian regional center

Eliša Papić

Croatian Medical Journal, 2022

View PDFchevron_right

Challenges in treating people with Parkinson’s disease during the COVID-19 pandemic

girlene pessoa

2020

View PDFchevron_right

Multidimensional Factors Can Explain the Clinical Worsening in People With Parkinson's Disease During the COVID-19 Pandemic: A Multicenter Cross-Sectional Trial

HUGO MACHADO SANCHEZ

Frontiers in Neurology, 2021

View PDFchevron_right

Best practice approaches to outpatient management of people living with Parkinson’s disease during the COVID-19 pandemic

Erica Westenberg

Journal of Neural Transmission, 2022

View PDFchevron_right

Correlation of COVID-19 with Parkinson’s disease and life expectancy indicates female population predominance in future

Aslam Pathan

2021

View PDFchevron_right

An educational case series of Parkinson's disease during the COVID-19 pandemic

Rita Lo Monaco

Revue Neurologique, 2020

View PDFchevron_right

The impact of SARS-COV2 infection on people in residential care with Parkinson Disease or parkinsonisms: Clinical case series study

Vincenzo Cimino

PLOS ONE

View PDFchevron_right

Parkinson's Disease and COVID ‐19: Perceptions and Implications in Patients and Caregivers

vikram holla

Movement Disorders, 2020

View PDFchevron_right

Impact of Isolation During the COVID-19 Pandemic on the Patient Burden of Parkinson’s Disease: A PMD Alliance Survey

Sherrie Gould

Neuropsychiatric Disease and Treatment, 2022

View PDFchevron_right

The impact of COVID-19 on palliative care for people with Parkinson’s and response to future pandemics

Maria Pimentel Piemonte

Expert Review of Neurotherapeutics

View PDFchevron_right

Changes in non-motor symptoms in patients with Parkinson's disease following COVID-19 pandemic restrictions: A systematic review

Francesca Mameli

Frontiers in Psychology

View PDFchevron_right

Impact of Covid-19 on research and training in Parkinson's disease

Silvia Rota

International Review of Neurobiology

View PDFchevron_right

The Influence of Coronavirus Disease-2019 (COVID-19) On Parkinson’s Disease: An Updated Systematic Review

Azza Sarfraz

Journal of Primary Care & Community Health

View PDFchevron_right

Lockdown effects on Parkinson’s disease during COVID-19 pandemic: a pilot study

Marika Falla

Acta Neurologica Belgica

View PDFchevron_right

Impact of home confinement during COVID-19 pandemic on Parkinson's disease

Bhushan Mishal

Parkinsonism & Related Disorders, 2020

View PDFchevron_right

COVID-19 and Parkinson’s disease: a casual association or a possible second hit in neurodegeneration?

Manuela Napoli

Journal of Neurology

View PDFchevron_right